Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
556 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Genotype-phenotype correlations and mutation spectrum of GBA1 in Gaucher disease across Asian populations: a systematic review.
Konarbayeva A, Atavliyeva S, Auganova D, Baduanova S, Tarlykov P. · Hum Genomics · 2026 · cited 0 timesOpen accessmeta-analysis, research support, non-u.s. gov't
- Frailty, clinical outcomes, and treatment effects of a care bundle in acute intracerebral haemorrhage: a post-hoc analysis of the INTERACT3 trial.
Liu T, Chen L, Liu Y, Zhao Z, Liu L, Ma L, Billot L, Li Q, Malavera A, Muñoz-Venturelli P, de Silva A, Thang NH, Wahab KW, Pandian JD, Wasay M, Pontes-Neto OM, Jiang R, Abanto C, Arauz A, Song L, Harris K, Lindley RI, Peters R, Ward DD, Rockwood K, Hu X, You C, Anderson CS, Chen X, INTERACT3 Investigators. · Lancet Healthy Longev · 2026 · cited 0 timesmulticenter study, randomized controlled trial
- A Randomized, Double-Blinded, Placebo-Controlled QTc Study to Evaluate BIA 28-6156 Effect on Cardiac Repolarization in Healthy Volunteers.
Peixoto I, Hilt D, Carvalho T, Reis J, Gama H, Holenz J. · Clin Pharmacol Drug Dev · 2026 · cited 0 timesOpen accessclinical trial, phase i, randomized controlled trial
- Investigating the therapeutic profile of velaglucerase alfa in paediatric patients with Gaucher disease: a systematic review across all paediatric age groups.
de Las Heras J, Cebolla JJ, de Pedro S, Gómez-Barrera M, Vitoria I. · Orphanet J Rare Dis · 2026 · cited 0 timesOpen accesssystematic review
- Health and well-being of mothers and co-parents during the first 12 months post partum: study protocol of the national SOCRATES cohort study in Switzerland.
Gaucher L, Desplanches T, Sormani J, Cattani G, Mueller AN, Celetta E, Widmer IN, Lorthe E, Grylka-Baeschlin S. · BMJ Open · 2026 · cited 0 timesOpen accessclinical trial protocol
- A Randomized, Double-Blind, 2-Treatment, 2-Period, Crossover Phase 1 Study to Compare the Pharmacokinetics, Safety and Tolerability of 60 IU/Kg of Abcertin and Cerezyme in Healthy Volunteers Following a Single Intravenous Administration.
Kang E, Kim D, Hwang S, Lemech C, Wharton J, Lee Y, Yoo HW, Lee BH. · Mol Genet Genomic Med · 2025 · cited 1 timesOpen accessclinical trial, phase i, randomized controlled trial
- Automated glucose control systems in post-pancreatectomy diabetes: systematic review of clinical efficacy and nursing care implications.
Alaimo CG, Bianchi F, Mancin S, Fidato B, Cattani D, Valsecchi A, Chiari C, Cangelosi G, Parozzi M, Scollo S, Cosmai S, Lopane D, Mazzoleni B. · Minerva Gastroenterol (Torino) · 2026 · cited 0 timessystematic review
- Evidence for long-term CD8<sup>+</sup> memory and functionally diverse CD4<sup>+</sup> helper responses following yellow fever vaccination: a systematic review.
Camara OL, Strandmark J, Goodier MR, Clarke E. · Front Immunol · 2026 · cited 0 timesOpen accessresearch support, non-u.s. gov't, systematic review
- Sex differences in the clinical and surgical management after intracerebral hemorrhage: A post hoc analysis of the INTERACT3 clinical trial.
Allende MI, Carcel C, Muñoz-Venturelli P, Harris K, Ouyang M, Ma L, Chen X, Billot L, Li Q, Malavera A, Li X, de Silva A, Nguyen TH, Wahab KW, Pandian JD, Wasay M, Pontes-Neto OM, Abanto C, Arauz A, You C, Hu X, Song L, Anderson CS, INTERACT3 Investigators. · Int J Stroke · 2026 · cited 0 timesmulticenter study, randomized controlled trial
- Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry Disease.
Germain DP, DasMahapatra P, Liu S, Deegan P, Ortiz A, Modur V, Wilcox WR. · Mol Genet Genomic Med · 2025 · cited 3 timesOpen accessclinical trial, phase iii, clinical trial, phase ii
- Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery: The EMMA-Can Randomized Clinical Trial.
Shankar JJS, Alcock S, Kashani N, Darsaut T, Wang BH, Dos Santos MP, Milot G, O'Kelly C, Kelly ME, Iancu D, Cora A, Marotta T, van Adel B, Kishore K, Drake B, Lesiuk H, Carrondo-Cottin S, Rempel J, Ahmed U, Chaalala C, Silvaggio J, Kaderali Z, McEachern J, Salam MSA, Sinha N, Marin R, Leung YS, Balshaw R, Fleetwood I, Jiang D, Menon BK, Singh N, Zeiler FA, EMMA-Can investigators. · JAMA · 2026 · cited 5 timescomparative study, multicenter study
- GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility.
Parlar SC, Lee Y, Gan-Or Z. · Mov Disord · 2026 · cited 1 timesOpen accessmeta-analysis, brief-report
- A 6-month randomized controlled trial for vitamin E supplementation in pediatric patients with Gaucher disease: Effect on oxidative stress, disease severity and hepatic complications.
Adly AAM, Ismail EAR, Ibrahim FA, Atef M, El Sayed KA, Aly NH. · J Inherit Metab Dis · 2025 · cited 4 timesrandomized controlled trial
- Self-reported perspective in rare genetic diseases: a systematic review of patient-reported outcome measures classified using the international classification of functioning, disability and health framework.
Simeon R, Usai M, Tramonti A, Canova R, Frigerio D, Berardi A, Pelosin E, Cosentino C. · J Patient Rep Outcomes · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Sphingolipids in Gaucher disease: a systematic review.
Lake A, Fuller M. · Orphanet J Rare Dis · 2025 · cited 4 timesOpen accessresearch support, non-u.s. gov't, systematic review
- A bibliometric analysis of alpha-synuclein in Parkinson's disease from 2015 to 2024.
Xiao L, Lin S, Wu Y, Liu X, Gu D, Fan J, Zhuang L. · Front Neurol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Long Term Metabolic Outcomes Following Pancreatectomy and Autologous Islet Transplantation: Systematic Review and Meta-Analysis.
Hughes DL, Di Bella C, Quaratino B, Rigo P, Cirillo G, Sgrinzato G, Cillo U, Furian L, Marchegiani G. · J Surg Oncol · 2026 · cited 1 timesOpen accessmeta-analysis, systematic review
- Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-Analysis.
Boeddinghaus J, Lopez-Ayala P, Thurston AJF, Lee KK, Tew YY, Doudesis D, Kadesjö E, Roos A, Raphael CE, Sandoval Y, Gulati R, Taggart C, Wereski R, Koechlin L, Anand A, Mahfoud F, Neumann JT, Strauß B, Sörensen NA, Smilowitz NR, Newby DE, Mueller C, Jaffe A, Mills NL, Vallejos CA, Chapman AR, MI-2 Collaborators. · J Am Coll Cardiol · 2026 · cited 2 timesmeta-analysis
- Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers.
Dong L, Xiang J, Babcock M, Cheng Y, Wang Y, Shen Y, Li L, Tan L, Garovoy M, Hu W, Zheng J. · Clin Drug Investig · 2024 · cited 2 timesclinical trial, phase i, randomized controlled trial
- Health utility values associated with pharmaceutical treatment process attributes: a systematic review and meta-analysis.
Liu Y, Du X, Rong Z, Guo Z, Chang F, Lu Y, Dai Z, Lu Y. · Health Qual Life Outcomes · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Adults With Acid Sphingomyelinase Deficiency Have Sustained Improvements in Clinical Outcomes With up to 5 Years of Olipudase Alfa Enzyme Replacement Therapy: ASCEND Trial Final Results.
Wasserstein MP, Hollak CE, Barbato A, Gallagher RC, Giugliani R, Guelbert NB, Hennermann JB, Ikezoe T, Lachmann R, Lidove O, Mabe P, Mengel E, Scarpa M, Senates E, Tchan M, Thurberg BL, Villarrubia J, Armstrong NM, Bhushan S, Kim Y, Kumar M. · J Inherit Metab Dis · 2026 · cited 3 timesOpen accessrandomized controlled trial
- A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis.
Langford CA, Khalidi N, Springer J, Friedman M, Hellmich B, Pagnoux C, Dehghan N, Gewurz-Singer O, Koening CL, Lin YC, Monach PA, Moreland LW, Fifi-Mah A, Flossmann O, Forbess LJ, Lanyon P, Molloy E, Specks U, Spiera R, Yacyshyn E, McAlear CA, Burroughs C, Jones RB, Rhee RL, Hajj-Ali R, Warrington KJ, Cuthbertson D, Krischer JP, Jayne D, Merkel PA, Vasculitis Clinical Research Consortium and the European Vasculitis Society. · Arthritis Rheumatol · 2025 · cited 8 timesOpen accessmulticenter study, randomized controlled trial
- Population Pharmacokinetic/Pharmacodynamic Modeling of Therapeutic Enzymes in Lysosomal Storage Diseases.
Barzel I, van der Ploeg AT, Pijnappel WWMP, van der Kuy PHM, van den Hout JMP, Preijers T. · Clin Pharmacokinet · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Thrombolysis in non-ST-elevation myocardial infarction: systematic review and meta-analysis of randomised controlled trials.
de Alencar JN, Oliveira MHJ, Bulhoes E, Farias CA, Kabariti JC, Carvalho HC, Meyers HP, Smith SW. · Open Heart · 2025 · cited 2 timesOpen accessmeta-analysis, systematic review
- Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes.
Lewis GA, Hughes DM, Irving GJ, Wilding JP, Hardy KJ. · Diabetes Obes Metab · 2026 · cited 1 timesOpen accessrandomized controlled trial
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.